# Eli Lilly (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/eli-lilly-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 51.5 |
| Citations | 5,172,606 |
| City | Indianapolis |
| Country | US |
| Description | Eli Lilly (United States) is a research organisation in Indianapolis, US. OpenAlex records 32,337 works and 5,172,606 citations for it. 9,193 researchers list it as their most recent affiliation. |
| Homepage | http://www.lilly.com/ |
| OpenAlex ID | https://openalex.org/I168537998 |
| Region | Indiana |
| Researchers | 9,193 |
| ROR ID | https://ror.org/01qat3289 |
| Type | company |
| Works | 32,337 |

## University papers

Showing 12 of 286.

- [10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes](https://scholariq.org/papers/10-year-follow-up-of-intensive-glucose-control-in-type-2-diabetes/)
- [The GTEx Consortium atlas of genetic regulatory effects across human tissues](https://scholariq.org/papers/the-gtex-consortium-atlas-of-genetic-regulatory-effects-across-human-tissues/)
- [The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods](https://scholariq.org/papers/the-alzheimer-s-disease-neuroimaging-initiative-adni-mri-methods/)
- [Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial](https://scholariq.org/papers/secondary-prevention-of-macrovascular-events-in-patients-with-type-2-diabetes-in/)
- [Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range](https://scholariq.org/papers/clinical-targets-for-continuous-glucose-monitoring-data-interpretation/)
- [Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans](https://scholariq.org/papers/quantitative-insulin-sensitivity-check-index-a-simple-accurate-method-for/)
- [Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients](https://scholariq.org/papers/mutational-landscape-of-metastatic-cancer-revealed-from-prospective-clinical/)
- [Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations](https://scholariq.org/papers/interpreting-the-clinical-importance-of-treatment-outcomes-in-chronic-pain/)
- [Multiple Wearable Sensors in Parkinson and Huntington Disease Individuals: A Pilot Study in Clinic and at Home](https://scholariq.org/papers/multiple-wearable-sensors-in-parkinson-and-huntington-disease-individuals-a/)
- [Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial](https://scholariq.org/papers/dulaglutide-and-cardiovascular-outcomes-in-type-2-diabetes-rewind-a-double-blind/)
- [Functional Reach: A New Clinical Measure of Balance](https://scholariq.org/papers/functional-reach-a-new-clinical-measure-of-balance/)
- [A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease](https://scholariq.org/papers/a-polymer-based-paclitaxel-eluting-stent-in-patients-with-coronary-artery/)

## University researchers

Showing 15 of 21.

- [Robert J. Heine](https://scholariq.org/researchers/robert-j-heine/)
- [Lucio G. Costa](https://scholariq.org/researchers/lucio-g-costa/)
- [Ann Marie Hake](https://scholariq.org/researchers/ann-marie-hake/)
- [Kevin Biglan](https://scholariq.org/researchers/kevin-biglan/)
- [Kevin L. Duffin](https://scholariq.org/researchers/kevin-l-duffin/)
- [Mark Lakshmanan](https://scholariq.org/researchers/mark-lakshmanan/)
- [Lars Viktrup](https://scholariq.org/researchers/lars-viktrup/)
- [Haya Ascher‐Svanum](https://scholariq.org/researchers/haya-ascher-svanum/)
- [Molly C. Carr](https://scholariq.org/researchers/molly-c-carr/)
- [Fady T. Botros](https://scholariq.org/researchers/fady-t-botros/)
- [Alan G. Zimmermann](https://scholariq.org/researchers/alan-g-zimmermann/)
- [Orin M. Goldblum](https://scholariq.org/researchers/orin-m-goldblum/)
- [Shonda A. Foster](https://scholariq.org/researchers/shonda-a-foster/)
- [Adrienne M. Gilligan](https://scholariq.org/researchers/adrienne-m-gilligan/)
- [Gilwan Kim](https://scholariq.org/researchers/gilwan-kim/)

## University top topics

Showing 8 of 25.

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Receptor Mechanisms and Signaling](https://scholariq.org/topics/receptor-mechanisms-and-signaling/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Neuroscience and Neuropharmacology Research](https://scholariq.org/topics/neuroscience-and-neuropharmacology-research/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Treatment of Major Depression](https://scholariq.org/topics/treatment-of-major-depression/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.